Detalles de la búsqueda
1.
NET-02: a randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma.
EClinicalMedicine
; 60: 102015, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37287870
2.
Management of uncommon chemotherapy-induced emergencies.
Lancet Oncol
; 12(8): 806-14, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21276754
3.
Evaluating Alternative Ramucirumab Doses as a Single Agent or with Paclitaxel in Second-Line Treatment of Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma: Results from Two Randomized, Open-Label, Phase II Studies.
Cancers (Basel)
; 14(5)2022 Feb 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35267477
4.
Glycogen synthase kinase 3 protein kinase activity is frequently elevated in human non-small cell lung carcinoma and supports tumour cell proliferation.
PLoS One
; 9(12): e114725, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25486534
5.
Study to determine adequate margins in radiotherapy planning for esophageal carcinoma by detailing patterns of recurrence after definitive chemoradiotherapy.
Int J Radiat Oncol Biol Phys
; 73(3): 818-23, 2009 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18718726
Resultados
1 -
5
de 5
1
Próxima >
>>